Controlled release levodopa/carbidopa (Sinemet CR4) in Parkinson's disease – an open evaluation of efficacy and safety
- 1 August 1991
- journal article
- clinical trial
- Published by Wiley in Australian and New Zealand Journal of Medicine
- Vol. 21 (4), 397-400
- https://doi.org/10.1111/j.1445-5994.1991.tb01337.x
Abstract
Twenty patients with moderately severe Parkinson's disease entered an open study of the efficacy and safety of a slow release preparation containing levodopa 200 mg and carbidopa 50 mg per tablet ('Sinemet CR4'). Following an initial four week baseline stabilisation period on conventional 'Sinemet' tablets, the patients were transferred to 'Sinemet CR4' and observed at intervals over the next 12 months. Fifteen patients completed the full year observation period. When compared with the baseline period, treatment with 'Sinemet CR4' was associated with longer periods of functional improvement and less fluctuation of response following each dose. The median (range) dose frequency was reduced from three (three-12) to two (two-seven) times daily (p less than 0.001) on 'Sinemet CR4' although median (range) total daily dose of levodopa was increased from 700 (375-2525) to 800 (400-2800) mg without any increase in adverse effects. Three patients developed peripheral neuropathy while receiving Sinemet CR4, but the association with this therapy is unclear. Overall 'Sinemet CR4' allowed a longer dosage interval and provided more stable control of disease manifestations than conventional 'Sinemet'.Keywords
This publication has 11 references indexed in Scilit:
- An Open Trial of Controlled Release Carbidopa/L-DOPA (Sinemet CR) for the Treatment of Mild-to-Moderate Parkinsonʼs DiseaseClinical Neuropharmacology, 1989
- A double-blind crossover comparison of Sinemet CR4 and standard Sinemet 25/100 in patients with Parkinson's disease and fluctuating motor performance.Journal of Neurology, Neurosurgery & Psychiatry, 1989
- Controlled-Release Sinemet (CR-4): A Double-Blind Crossover Study in Patients With Fluctuating Parkinson's DiseaseMayo Clinic Proceedings, 1988
- Controlled‐release carbidopa/levodopa (CR4‐Sinemet) in Parkinson's disease patients with and without motor fluctuationsNeurology, 1988
- Controlled‐release levodopa/carbidopa.Neurology, 1987
- Parkinson's disease and motor fluctuationsNeurology, 1987
- Control of on/off phenomenon by continuous intravenous infusion of levodopaNeurology, 1984
- On‐off responseNeurology, 1975
- ParkinsonismNeurology, 1967
- A METHOD FOR EVALUATING DISABILITY IN PATIENTS WITH PARKINSONʼS DISEASEThe Journal of Nervous and Mental Disease, 1961